Stock data
Anixa Biosciences, Inc. (ANIX)
Anixa Biosciences, Inc. (ANIX) reported net income of -US$10.93M for fiscal 2025. The figures below come from the company's SEC filings.
Annual results
Data as of 2025-10-31
| Fiscal year | Revenue | Gross profit | Operating income | Net income | Diluted EPS |
|---|---|---|---|---|---|
| 2025 | — | — | -US$11.70M | -US$10.93M | — |
| 2024 | US$0.21M | — | -US$13.83M | -US$12.55M | — |
| 2023 | US$0.21M | — | -US$11.01M | -US$9.81M | — |
| 2022 | — | — | -US$13.88M | -US$13.60M | — |
| 2021 | US$0.51M | — | -US$13.14M | -US$12.95M | — |
Quarterly results
Data as of 2026-07-31
| Quarter | Revenue | Net income | Diluted EPS |
|---|---|---|---|
| 2026-07-31 | — | -US$2.61M | — |
| 2026-04-30 | — | -US$2.52M | — |
| 2026-01-31 | — | -US$2.56M | — |
| 2025-10-31 | — | -US$2.69M | — |
| 2025-07-31 | — | -US$2.26M | — |
| 2025-04-30 | — | -US$2.79M | — |
| 2025-01-31 | — | -US$3.18M | — |
| 2024-10-31 | — | -US$2.88M | — |
Sources
- Source: SEC EDGAR company facts
Charts, drawing tools, and the P/E calculator are in the app, free to use.